Anzeige
Mehr »
Login
Mittwoch, 12.05.2021 Börsentäglich über 12.000 News von 660 internationalen Medien
Glow LifeTech: Weitere positive Studien für das COVID-Wundermittel ArtemiC?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
277 Leser
Artikel bewerten:
(1)

Cloud DX Inc.: Cloud DX Announces Intention to Participate in the Government of Canada's Expansion of Virtual Care

WATERLOO, ON / ACCESSWIRE / April 22, 2021 / Cloud DX (TSX.V:CDX), a leading Canadian provider of virtual care and remote patient monitoring solutions, announced its support and intention to participate in offering its award-winning remote patient monitoring platform, the Cloud DX Connected Health Kit to provincial and territory healthcare providers as part of the Government of Canada's newly signed bilateral agreement to enhance provincial virtual care services, including $46M in funding flowing to the Province of Ontario. Remote patient monitoring is identified as one of five priority areas for immediate action.

"With the COVID-19 third wave upon us, there is heightened urgency to act swiftly and decisively to bring virtual care services to every Canadian. Now is the time for the private and public sector to come together like never before to ensure people across this country have continued access to the health care services they need virtually during this time of great uncertainty. With a fully commercialized, Health Canada compliant, made-in-Canada solution at the ready, Cloud DX is standing by to bring our easy to use, easy to adopt remote patient monitoring solution to healthcare providers across this country. Connected Health is already in use from coast-to-coast, including for COVID-19 patients, and our message to hospital administrators, doctors, and other care providers is this: we are ready to assist and can have you and your patients up and running very quickly," says Robert Kaul, CEO of Cloud DX

Cloud DX

Accelerating virtual healthcare's future, Cloud DX is making healthcare better for everyone. The company's Connected Health remote patient monitoring platform is used by healthcare enterprises and care teams across North America to virtually manage chronic disease, enable ageing in place and deliver hospital-quality post-surgical care. Providers partnering with Cloud DX achieve better healthcare and patient outcomes, reduce the need for hospitalization/re-hospitalization and reduce the costs of healthcare delivery through more efficient use of resources. Cloud DX is the co-winner of the Qualcomm Tricorder XPRIZE, a 2021 Edison Award winner, a Fast Company "World Changing Idea" finalist and one of Canada's 10 most prominent Telehealth providers.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Social Links

Twitter: https://twitter.com/CloudDX
Facebook https://www.facebook.com/clouddxinc/
LinkedIn https://www.linkedin.com/company/cloud-dx/

For media inquiries please contact:

Ellyn Winters-Robinson
Ignition Communications (PR for Cloud DX)
519-574-2196
ellyn@ignition.ca

For investor inquiries please contact:

Jay Bedard
Cloud DX Investor Relations
647-881-8418
jay.bedard@CloudDX.com

Cloud DX Corporate Contact

Robert Kaul
CEO
1-646-706-1807
Robert.kaul@clouddx.com

SOURCE: Cloud DX Inc.



View source version on accesswire.com:
https://www.accesswire.com/641829/Cloud-DX-Announces-Intention-to-Participate-in-the-Government-of-Canadas-Expansion-of-Virtual-Care

Kostenloser Wertpapierhandel auf Smartbroker.de
© 2021 ACCESSWIRE
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.